|
| |
KIT
Gene Information from Publications |
| Publication Link |
Summary of findings |
| 17726262 |
The frequency of KIT overexpression in gliomas was assessed and the genetic mechanisms underlying KIT overexpression were investigated. |
| 18270328 |
Observational study of gene-disease association. (HuGE Navigator) |
| 18212542 |
CD117 proved to be a very sensitive marker of Atypical fibroxanthoma |
| 17960171 |
c-KIT but not CSF1R mutations play a role in the leukemogenesis of childhood CBF-AML |
| 17645464 |
The size of the mucosal mast cell (MC) population in patients with inactive inflammatory bowel disease (IBD) is not altered by disease or by stress, yet MC in IBD are different (fewer c-kit receptors) and respond differently (greater activation). |
| 18259950 |
Exon 11 mutation of CD-117 is associated with gastrointestinal stromal tumor |
| 18265633 |
c-kit protein expression may play an important role in neoplasia of pancreatic neoplasms. |
| 18265649 |
C-kit oncogenic mutations are more likely seen in CD-117-positive GISTs arising in the gastrointestinal tract and have no obvious relationship with biological behavior of GISTs. |
| 18006222 |
Presence of c-kit gene mutations in testicular germ cell tumours may not be associated with bilateral diseases, at least in Japan. |
| 16015387 |
Observational study of gene-disease association. (HuGE Navigator) | →View more information from publications. |
Recent Publications on KIT: |  |
Multiple gastrointestinal stromal tumors in neurofibromatosis type 1: Report of a case.
This report presents a case of multiple gastrointestinal stromal tumors... | 3rd November, 2009
| Department of Gastroenterological Surgery, Kumamoto University, 1-1-1
| Surg Today. 2009;39(11):979-83. Epub 2009 Nov 1.
DOI Direct Link |
Breviscapine ameliorates cardiac dysfunction and regulates the myocardial Ca(2+)-cycling proteins in streptozotocin-induced diabetic rats.
To investigate the influence of breviscapine on the cardiac structure and... | 3rd November, 2009
| Key Laboratory of Biotherapy of Zhejiang Province, Department of
| Acta Diabetol. 2009 Oct 31.
DOI Direct Link |
Fatal abdominal sarcomatosis secondary to gastrointestinal stromal tumor with bland histology.
Fatal abdominal sarcomatosis is a rare complication secondary to... | 3rd November, 2009
| Department of Pathology and Laboratory Medicine, James H. Quillen VA
| Saudi Med J. 2009 Nov;30(11):1469-72.
|
Nucleic acid amplification technology for hepatitis B virus, and its role in blood donation screening in blood banks.
OBJECTIVE: To investigate the performance of hepatitis B virus polymerase... | 3rd November, 2009
| Department of Molecular Pathology, Al-Hada Armed Forces Hospital, Taif,
| Saudi Med J. 2009 Nov;30(11):1416-21.
|
Carney triad in an adult with aggressive behavior: the first case in Korea.
Carney triad is a rare syndrome of unknown etiology characterized by... | 3rd November, 2009
| Department of Pathology, Samsung Medical Center, Sungkyunkwan University
| Yonsei Med J. 2009 Oct 31;50(5):709-12. Epub 2009 Oct 21.
DOI Direct Link |
→View more research publications. |
Press Releases on KIT:
|
 |
| Bayer and Onyx Announce Nexavar Data Presentations at 60th American Association for the Study of Liver Diseases Annual Meeting |
29th October, 2009 |
Onyx Pharmaceuticals, Inc. |
-- Late Breaker #9
First-in-men Demonstration of Sorafenib Plus TACE for the Treatment of Advanced Hepatocellular Carcinoma (SOCRATES trial)
--
|
| Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Patients With Non-Responsive Thyroid Cancer |
23rd October, 2009 |
Onyx Pharmaceuticals, Inc. |
WAYNE, N.J. and EMERYVILLE, Calif., Oct. 23 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today
|
| Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cancer |
30th September, 2009 |
Onyx Pharmaceuticals, Inc. |
WAYNE, N.J. and EMERYVILLE, Calif., Sept. 30 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced results
|
| MDOUTLOOK(R) Quick Polls Report on Clinical Integration of Key Oncology Developments Following ASCO 2009 |
24th June, 2009 |
The Arcas Group |
ATLANTA, June 24 /PRNewswire/ -- MDOUTLOOK(R), the innovative oncology intelligence platform, today announced the results from its Quick Poll research, which was launched immediately following
|
| Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer |
1st June, 2009 |
Bayer HealthCare Pharmaceuticals, Inc. |
WAYNE, N.J. and EMERYVILLE, Calif., June 1 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that the companies have
|
KIT results (if any) from reagent suppliers | 
|
Search Bioportfolio and other Life Science Sites for KIT,
or search for KIT on BioPortfolio's antibody search engine.
This page has been viewed 817 times
Recent Search Terms used to find this page: cat blood matching kit | The Halevy Treatment Kit | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | the symbol of c KIT gene | Feline Sarcoma Viral Oncogene | feline inflammatory bowel disease | v-kit gene | Kit v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | KIT v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | .
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|
